Immunology

Latest News

infliximab biosimilars are used to treat Inflammatory bowel disease | Image credit: sdecoret - stock.adobe.com
Real-World Data Suggest Long-Term Safety of CT-P13 in IBD, RA

July 2nd 2025

The MEGA-J study reveals CT-P13's long-term safety and effectiveness in treating inflammatory bowel disease and rheumatoid arthritis, with minimal adverse reactions.

Smart phone app that tracks medical data | Image Credit: Maksym - stock.adobe.com
Adalimumab Double Take: The Unexpected Return to Reference Humira

June 30th 2025

eye on pharma banner
Eye on Pharma: CHMP Aflibercept Decision; Omalizumab Results; Dupilumab Biosimilar Deal

June 26th 2025

child with IBD | Image credit: Art_Photo - stock.adobe.com
Increasing Biosimilar Use Reflects Changing Practice in Pediatric IBD Care

June 25th 2025

skin allergy reaction | image credit: NATALYA - stock.adobe.com
Omalizumab Biosimilar Matches Reference Product in Chronic Spontaneous Urticaria

June 24th 2025

Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CFB podcast banner
CfB podcast banner
CFB podcast banner
Latest CME Events & Activities

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology

View More

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Immunology, Neurology

View More

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

View More

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

August 13, 2025 | 1:00 PM & 8:00 PM EDT

View More

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape for Managed Care Professi...

August 19, 2025 | 1:00 PM & 8:00 PM ET

View More

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

August 21, 2025 | 1:00 PM ET & 8:00 PM ET

View More

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

View More

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

View More

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology

View More

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

1.5 Credits / Allergy, Immunology

View More

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

View More

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

1.5 Credits / Immunology, Allergy

View More

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology

View More

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Car...

1.5 Credits / Immunology

View More

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

1.5 Credits / Gastroenterology, Immunology

View More

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care...

1.5 Credits / Gastroenterology, Immunology

View More

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updat...

1.0 Credit / Immunology, Nephrology

View More

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

1.0 Credit / Immunology, Nephrology

View More

More News

© 2025 MJH Life Sciences

All rights reserved.